4.4 Article

OFraMP: a fragment-based tool to facilitate the parametrization of large molecules

Journal

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Volume 37, Issue 8, Pages 357-371

Publisher

SPRINGER
DOI: 10.1007/s10822-023-00511-7

Keywords

Molecular fragments; Force fields; Automated topology builder; Partial charges; Drugs; Dendrimer; Molecular simulation

Ask authors/readers for more resources

OFraMP is an online tool that assigns atomic interaction parameters to large molecules by matching sub-fragments within the target molecule to equivalent sub-fragments within the ATB database. It uses a novel hierarchical matching procedure and allows users to manually alter interaction parameters and automate the submission of missing substructures to the ATB. The utility of OFraMP is demonstrated using the anti-cancer agent paclitaxel and a dendrimer used in organic semiconductor devices.
An Online tool for Fragment-based Molecule Parametrization (OFraMP) is described. OFraMP is a web application for assigning atomic interaction parameters to large molecules by matching sub-fragments within the target molecule to equivalent sub-fragments within the Automated Topology Builder (ATB, atb.uq.edu.au) database. OFraMP identifies and compares alternative molecular fragments from the ATB database, which contains over 890,000 pre-parameterized molecules, using a novel hierarchical matching procedure. Atoms are considered within the context of an extended local environment (buffer region) with the degree of similarity between an atom in the target molecule and that in the proposed match controlled by varying the size of the buffer region. Adjacent matching atoms are combined into progressively larger matched sub-structures. The user then selects the most appropriate match. OFraMP also allows users to manually alter interaction parameters and automates the submission of missing substructures to the ATB in order to generate parameters for atoms in environments not represented in the existing database. The utility of OFraMP is illustrated using the anti-cancer agent paclitaxel and a dendrimer used in organic semiconductor devices.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available